FLUORESCEIN Drug Patent Profile
✉ Email this page to a colleague
When do Fluorescein patents expire, and what generic alternatives are available?
Fluorescein is a drug marketed by Bpi Labs, Nexus, Zydus Lifesciences, and Bausch Lomb Ireland. and is included in four NDAs. There are three patents protecting this drug.
The generic ingredient in FLUORESCEIN is benoxinate hydrochloride; fluorescein sodium. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the benoxinate hydrochloride; fluorescein sodium profile page.
DrugPatentWatch® Generic Entry Outlook for Fluorescein
Indicators of Generic Entry
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for FLUORESCEIN?
- What are the global sales for FLUORESCEIN?
- What is Average Wholesale Price for FLUORESCEIN?
Summary for FLUORESCEIN
| US Patents: | 0 |
| Applicants: | 4 |
| NDAs: | 4 |
| Drug Prices: | Drug price information for FLUORESCEIN |
| What excipients (inactive ingredients) are in FLUORESCEIN? | FLUORESCEIN excipients list |
| DailyMed Link: | FLUORESCEIN at DailyMed |
US Patents and Regulatory Information for FLUORESCEIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bpi Labs | FLUORESCEIN SODIUM | fluorescein sodium | INJECTABLE;INTRAVENOUS | 220046-001 | Apr 30, 2026 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Bausch Lomb Ireland | FLUORESCEIN SODIUM AND BENOXINATE HYDROCHLORIDE | benoxinate hydrochloride; fluorescein sodium | SOLUTION/DROPS;OPHTHALMIC | 211039-001 | Mar 9, 2020 | RX | Yes | Yes | 10,632,197 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Zydus Lifesciences | FLUORESCEIN SODIUM | fluorescein sodium | INJECTABLE;INTRAVENOUS | 218651-001 | Jun 1, 2026 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Bausch Lomb Ireland | FLUORESCEIN SODIUM AND BENOXINATE HYDROCHLORIDE | benoxinate hydrochloride; fluorescein sodium | SOLUTION/DROPS;OPHTHALMIC | 211039-001 | Mar 9, 2020 | RX | Yes | Yes | 10,293,047 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
